Bailard’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,700
| Closed | -$128K | – | 825 |
|
|
2024
Q1 | $128K | Buy |
+13,700
| New | +$128K | ﹤0.01% | 716 |
|
|
2022
Q4 | – | Sell |
-28,900
| Closed | -$171K | – | 788 |
|
|
2022
Q3 | $171K | Buy |
+28,900
| New | +$171K | 0.01% | 616 |
|
|
2020
Q2 | – | Sell |
-140,700
| Closed | -$1.29M | – | 562 |
|
|
2020
Q1 | $1.29M | Sell |
140,700
-27,000
| -16% | -$247K | 0.09% | 154 |
|
|
2019
Q4 | $2.34M | Buy |
167,700
+50,200
| +43% | +$700K | 0.13% | 141 |
|
|
2019
Q3 | $2.02M | Buy |
117,500
+76,500
| +187% | +$1.32M | 0.12% | 154 |
|
|
2019
Q2 | $1.12M | Buy |
+41,000
| New | +$1.12M | 0.07% | 214 |
|
|
2018
Q4 | – | Sell |
-22,000
| Closed | -$416K | – | 564 |
|
|
2018
Q3 | $416K | Hold |
22,000
| – | – | 0.02% | 418 |
|
|
2018
Q2 | $430K | Buy |
22,000
+2,000
| +10% | +$39.1K | 0.03% | 398 |
|
|
2018
Q1 | $376K | Buy |
20,000
+6,000
| +43% | +$113K | 0.02% | 382 |
|
|
2017
Q4 | $232K | Buy |
+14,000
| New | +$232K | 0.01% | 405 |
|